This inventor holds 8 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Cancer Research Technology Limited, Ucl Business Plc, University College London. Active years: 2007-2023.
Location History:
- Hertfordshire, GB (2007)
- Bushey, GB (2007)
- Herts, GB (2016)
- London, GB (2007 - 2023)
Company Filing History:
4 out of 268 
2 out of 299 
2 out of 119 
Years Active: 2007-2023
Title: The Innovative Contributions of Stephen Neidle
Introduction
Stephen Neidle is a prominent inventor based in London, GB. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of 8 patents to his name, Neidle's work focuses on innovative solutions for cancer treatment.
Latest Patents
Among his latest patents, Neidle has developed substituted naphthalene diimides and their use. This invention relates to naphthalene diimides (NDIs) and methods of synthesizing them. The NDIs exhibit DNA-quadruplex binding and stabilizing activity, showing promise in the treatment of pancreatic, prostate, and other human cancers. The NDIs are characterized as a compound of Formula I. Another notable patent involves diimide compounds, which are novel naphthalene diimides of general formula (I). These compounds are particularly useful in therapy, especially for cancer treatment.
Career Highlights
Throughout his career, Stephen Neidle has worked with various organizations, including Cancer Research Technology Limited and UCL Business Plc. His innovative research has positioned him as a key figure in the field of cancer therapeutics.
Collaborations
Neidle has collaborated with notable individuals in his field, including Richard John Harrison and Lloyd Royston Kelland. These partnerships have further enhanced his research and contributions to cancer treatment.
Conclusion
Stephen Neidle's work exemplifies the impact of innovation in the field of cancer research. His patents and collaborations highlight his commitment to developing effective therapies for serious health conditions.